Preferred GLP-1 Receptor Agonists in Adults With Type 2 Diabetes and Established CVD or High CV Risk: A Network Meta-analysis of Randomized Trials
However, isolated case reports have documented rare instances of liver enzyme elevations during GLP-1 therapy, though causality is often difficult to establish given the multiple factors affecting liver health in obese patients
However, it is unlikely that taking a medication for diabetes will result in hair loss, with hair loss being reported as a possible side effect in a clinical trial for semaglutide (Wegovy, Ozempic) by only 3% of respondents
The Trap: If you add a massive block of expanding fiber to a digestive system that has stopped moving, it doesn't cure the constipationit creates painful bloating, gas, and severe impaction
International Journal of Oncology, 20 (1), 6975